Long-Acting Buprenorphine Formulations As A New Strategy For The Treatment Of Opioid Use DisorderMaremmani, I., Dematteis, M., Gorzelanczyk, E. J., Mugelli, A., Walcher, S., & Torrens, M. (2023). Long-acting buprenorphine formulations as a new strategy for the treatment of opioid use disorder. Journal of Clinical Medicine, 12(17), 5575. https://doi.org/10.3390/jcm12175575
This article addresses a potential new way of addressing the short-acting nature of current medication replacement treatments.